Rare diseases
Investigational molecules
Locations
Back to Czechia1 231 clinical trials in Prague, Czechia across 17 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in CzechiaKlinickeTesty.cz(opens in a new tab)Study on Tozorakimab for Patients Hospitalized with Severe Viral Lung Infections Needing Oxygen
CzechiaStudy on the Safety and Absorption of Meropenem and Vaborbactam in Children with Complicated Urinary Tract Infections
CzechiaStudy on the Effects of Obicetrapib and Ezetimibe on Coronary Plaque in Patients with Atherosclerotic Cardiovascular Disease
CzechiaStudy on Anifrolumab for Adults with Polymyositis or Dermatomyositis
CzechiaStudy on BI 690517 and Empagliflozin for Patients with Heart Failure and Preserved Ejection Fraction
CzechiaStudy on the Safety of BHV-7000 for Adults with Hard-to-Treat Focal Onset Epilepsy
CzechiaStudy on the Effectiveness and Safety of Oxymetazoline Hydrochloride Eye Drops for Adults with Acquired Blepharoptosis
CzechiaStudy on Selatogrel for Preventing Heart Attack in Patients with Recent Heart Attack History
CzechiaStudy of Elafibranor for Adults with Primary Biliary Cholangitis
CzechiaStudy of Dostarlimab After Chemoradiation for Adults with Advanced Unresected Head and Neck Cancer
CzechiaStudy on Long-Term Safety of Ianalumab for Patients with Systemic Lupus Erythematosus
CzechiaStudy on the Effects of MORF-057 for Adults with Moderate to Severe Crohn's Disease
CzechiaThe busiest research cities in the country
What the registry says about research in the country
Clinical trial activity in Praha includes research in advanced melanoma and diffuse large B-cell lymphoma, with a strong focus on improving cancer control and extending survival.
These studies are designed to refine how immunotherapy and other cancer treatments perform in everyday clinical care.
Research in cardiovascular diseases is centered on reducing major heart and vascular events, with trials looking at hypertension, atherosclerotic cardiovascular disease, and heart failure prevention.
Several studies aim to improve treatment effectiveness for patients at elevated cardiovascular risk.
Trials in the respiratory field focus on better symptom control and fewer flare-ups in chronic obstructive pulmonary disease, alongside ongoing work in infection-related lung illness.
These studies support more effective care for both chronic and acute respiratory conditions.
Dermatology research in Czechia includes several inflammatory skin disorders, with studies targeting itch, lesion control, and long-term disease management.
The goal is to evaluate new therapies that may ease symptoms and improve quality of life.
Studies in immune-mediated disease are exploring treatments that can calm abnormal inflammation while maintaining safety and tolerability.
These trials aim to improve control of chronic immune-driven disease burden.
Neurology-related research focuses on agitation in Alzheimer's disease dementia, with efforts to better manage behavioral symptoms that affect patients and caregivers.
These studies may help support more practical care for people living with dementia.
Metabolic research in Praha includes trials for overweight, obesity, and related conditions, often linked with cardiovascular risk.
These studies are testing approaches that may help reduce long-term health risks tied to excess weight.
In the area of virus diseases, research is centered on improving treatment options for people with COVID-19 who are at higher risk of becoming seriously ill.
The main aim is to help prevent worsening disease and support faster recovery.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
